{"symbol": "XTLB", "companyName": "XTL Biopharmaceuticals Ltd.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.xtlbio.com", "description": "XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.", "CEO": "Josh Levine", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}